Press release
North America Pain Management Market reaching USD 46.87 billion by 2033, led by Johnson & Johnson, Pfizer, Abbott Laboratories, and Boston Scientific | DataM Intelligence
North America Pain Management Market
United States: Recent Industry Developments
✅ In October 2025, Johnson & Johnson launched a novel non-opioid analgesic with 50% improved efficacy in chronic pain management.
✅ In September 2025, The U.S. FDA approved a new neuromodulation device for targeted pain relief, backed by USD 850 million in research funding.
✅ In August 2025, Pfizer introduced a digital therapeutic platform integrating AI for personalized pain management plans.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/north-america-pain-management-market?jd
Canada: Recent Industry Developments
✅ In October 2025, Abbott Laboratories received Health Canada approval for its next-generation spinal cord stimulation system with remote monitoring capabilities.
✅ In September 2025, The Canadian government allocated CAD 720 million for chronic pain management initiatives and public health programs.
✅ In August 2025, Boston Scientific launched a minimally invasive pain management device with real-time feedback for back pain treatment.
Mexico: Recent Industry Developments
✅ In October 2025, Medtronic expanded its pain management portfolio with localized solutions for the Mexican healthcare system.
✅ In September 2025, Mexico's Ministry of Health implemented updated clinical guidelines emphasizing multimodal and non-opioid therapies.
✅ In August 2025, Teva Pharmaceutical introduced a cost-effective biosimilar for inflammatory pain management.
Market Trends & Drivers
The North America Pain Management Market is experiencing steady growth driven by the rising prevalence of chronic pain conditions, an aging population, and increasing demand for non-opioid and alternative therapies. Key trends include the adoption of digital health solutions, advancements in neuromodulation technologies, and the integration of personalized medicine approaches. Growing awareness of the opioid crisis, supportive regulatory frameworks, and innovations in drug delivery systems are further accelerating market expansion.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/north-america-pain-management-market?jd
Competitive Landscape
The market is characterized by strong competition among pharmaceutical giants, medical device innovators, and biotechnology firms.
1. Johnson & Johnson leads with a diverse portfolio of pharmaceuticals and medical devices for pain management.
2. Pfizer Inc. dominates through its extensive range of analgesic products and ongoing R&D in non-opioid therapies.
3. Abbott Laboratories specializes in advanced neuromodulation and minimally invasive pain relief solutions.
4. Boston Scientific Corporation is a key player in innovative devices for chronic and neuropathic pain.
5. Medtronic plc offers comprehensive pain management systems, including spinal cord stimulators.
6. Teva Pharmaceutical Industries Ltd. provides a wide array of generic and specialty pain medications.
7. Eli Lilly and Company focuses on biologic and targeted therapies for inflammatory and chronic pain.
8. Novartis AG invests in next-generation analgesics and collaborative digital health initiatives.
9. Bayer AG supplies both prescription and OTC pain management products.
10. GlaxoSmithKline plc emphasizes consumer health and prescription solutions for pain relief.
Buy now and enjoy a 30% year-end discount - limited-time offer! https://www.datamintelligence.com/buy-now-page?report=north-america-pain-management-market?jd
(Purchase 2 or more Reports and get 50% Discount)
Segmentation
By Drug Type
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Opioids collectively represent the foundation of pain management, with NSAIDs dominating the over-the-counter segment for mild to moderate pain, while opioids remain critical for severe acute and cancer pain.
Anticonvulsant Drugs are the fastest-growing segment, driven by their increased adoption for treating neuropathic pain conditions.
By Indication
Arthritis Pain and Back Pain represent the largest indication segments, accounting for a significant portion of prescriptions due to their high global prevalence.
Neuropathic Pain is a rapidly growing segment, with increasing diagnosis and the development of targeted drug therapies fueling market expansion.
By Mode of Prescription
Prescription-Based drugs dominate the market share in terms of revenue, encompassing the majority of opioids, anticonvulsants, and stronger formulations used for moderate to severe pain.
Over-the-Counter (OTC) drugs lead in volume, with high consumer utilization of NSAIDs and other analgesics for common ailments like headaches, menstrual pain, and minor injuries.
By Distribution Channel
Retail Pharmacies are the largest distribution channel, serving as the primary access point for both prescription fulfillment and OTC purchases for chronic and acute pain management.
Online Pharmacies are projected to be the fastest-growing channel, fueled by increasing consumer preference for convenience, direct-to-door delivery, and often competitive pricing.
Regional Analysis:
The U.S. dominates the North American market share due to its high healthcare expenditure and advanced medical infrastructure. A significant prevalence of chronic pain conditions and strong patient awareness drives demand. Robust adoption of innovative pharmaceuticals, medical devices, and telehealth services for pain management further consolidates its leading position.
Canada holds a substantial share, supported by its universal public healthcare system ensuring broad access to pain treatments. The market is growing through government initiatives and increasing investment in non-opioid and alternative pain therapies. Rising focus on multidisciplinary pain clinics and the integration of new technologies also contribute to its market presence.
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg?jd
Related Reports:
1. Pain Management Devices Market - https://www.datamintelligence.com/research-report/pain-management-devices-market?jd
2. Pain Management Drugs Market - https://www.datamintelligence.com/research-report/pain-management-drugs-market?jd
3. Pain Management Alternatives Market - https://www.datamintelligence.com/research-report/pain-management-alternatives-market?jd
Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us:
DataM Intelligence is a full-service market research and consulting firm, guiding organizations from initial insight to strategic implementation. We transform proprietary data, emerging trends, and market developments into agile, actionable solutions.
Our robust methodology powers a vast research database featuring 6,300+ syndicated and custom reports across 40+ industries. We have delivered strategic solutions to 200+ companies in 50+ countries, addressing the core research challenges that drive growth for our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North America Pain Management Market reaching USD 46.87 billion by 2033, led by Johnson & Johnson, Pfizer, Abbott Laboratories, and Boston Scientific | DataM Intelligence here
News-ID: 4261372 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
United States Autonomous weapons Market is to reach US$ 33.47 billion by 2032 - …
According to DataM Intelligence, The Autonomous weapons Market reached US$ 14.12 billion in 2024 and is expected to reach US$ 33.47 billion by 2032, growing with a CAGR of 11.39% during the forecast period 2025-2032.
The Autonomous Weapons Market is growing due to advancements in AI, robotics, and sensor fusion that enhance precision and reduce human risk. Rising geopolitical tensions, defense modernization programs, and integration of 5G and edge computing for…
United States Alzheimer's Disease Therapeutics Market to hit US$ 46.47 billion b …
global alzheimer's disease therapeutics market size reached US$ 24.27 billion in 2024 and is expected to reach US$ 46.47 billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.
DataM Intelligence has released its latest report on the "Alzheimers Disease Therapeutics Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume),…
US Agricultural Machinery Market Growth Forecast 2025-2031: Market to Reach USD …
The Global Agricultural Machinery Market was valued at US$ 167.99 billion in 2024 and is projected to reach US$ 258.38 billion by 2033, growing at a CAGR of 4.9% during the forecast period (2025-2033). The market's expansion is driven by increasing farm mechanization, rising global food demand, and the adoption of smart farming technologies. Tractors, harvesters, and planting equipment dominate the market, with major manufacturers integrating automation, GPS, and AI-enabled…
North America and EU Sterile Injectables CMO Market to hit US$ 22.37 Billion by …
North America and Europe sterile injectables CMO market size reached US$ 9.83 Billion in 2024 from US$ 9.15 Billion in 2023 and is expected to reach US$ 22.37 Billion by 2033, growing at a CAGR of 9.8% during the forecast period 2025-2033.
DataM Intelligence has released its latest report on the "North America and Europe Sterile Injectables CMO Market Size 2025," providing a detailed analysis of market trends, key growth…
More Releases for Pain
Comprehensive Pain Management Services Expanded by Denver Pain Management Clinic
Image: https://www.globalnewslines.com/uploads/2025/01/1737464973.jpg
Denver Pain Management Clinic announces expanded services for individuals suffering from chronic pain conditions throughout the Denver metropolitan area. The clinic, established in 2010, continues to strengthen its position as a leading provider of comprehensive pain management services in Colorado through its team of specialized Denver Pain Doctors.
DENVER, CO - October 9, 2025 - Denver Pain Management Clinic [https://denverpainmanagementclinic.com/] announces expanded services for individuals suffering from chronic pain conditions…
Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg
Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain.
Personalized Treatment for Every Pain Disorder
Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,…
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe.
By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods.
So, have a pain-free life with easy-to-use pain relief…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction:
The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes.
In this article,…
